Navigation Links
Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Date:11/5/2007

MILWAUKEE, Nov. 5 /PRNewswire-USNewswire/ -- The following is a statement by Bonnie J. Campbell, former Attorney General of Iowa:

"Today a Milwaukee jury unanimously concluded that former manufacturers of lead pigment used decades ago to make paint are not responsible for the harm claimed by this plaintiff. The jury unanimously found that the plaintiff was not harmed by lead pigment in paint.

"Under Wisconsin law, property owners are legally responsible for keeping their properties free from lead paint hazards."


'/>"/>
SOURCE Atlantic Richfield Co.; NL Industries, Inc.; TheSherwin-Williams
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire/-SentinelleMedicalInc.,aleadingmanufactu...elaunchesasuiteofnewleadingedgeclinicalapplication...syear,sRadiologicalSocietyofNorthAmerica(RSNA)annu...lA).Theapplicationsleveragetheuniquehighqualityima...lsandsupportmultipleimagingmodalitiesformulti-para...
(Date:11/25/2009)....25/PRNewswire/--TheBayAreaAirQualityManagementDis...the Air Alert forThursday,November26,2009w...solidfuel,bothindoorsandoutdoors. ,, "Cold,stil...w,"saidJackBroadbent,executiveofficeroftheAirDistr...oftheirneighborsandfellowcommunitymembersthisThank...
(Date:11/25/2009)...ry that grew out of a collaboration between UCLA e...pe to the nearly 10 million Americans who suffer f...n as hardening of the arteries, peripheral arteria... in which narrowed arteries reduce blood flow to t...or vascular disease, heart attack and stroke, and ...
(Date:11/25/2009)... Evaluation and treatment clinics to resume Monda...ocus) November 25, 2009 -- Centegra Health System ...1 vaccine shots at four Centegra Primary Care (CPC...ccine has arrived. The clinics are at CPC sites in...will be open as follows: ,   From 4:30...
(Date:11/25/2009)...RNewswire/-- MISSIONSkincare ®isproudtosuppor...partofGNC,sannualSt.Jude ThanksandGiving campaign,...ew SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addi...5or$10donationatcheckoutatoneoftheir5,000+retaillo...nforSt.Judeduringtheir2009 ThanksandGiving campaig...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...oday by the National Quality Forum:h, WHAT: Natio...on Care,Coordination and 2008 Spring Membership Me...ualityforum.org ., March 26: Spring Membership Me...onvened by NQF that is identifying a,short list of...
...profen for arthritis pain or other conditions whil...roke undermine aspirins ability to act as an anti-...uffalo have shown. , In a cohort of patients seen...inflammatory drug, or NSAID) daily and all were fo...
...ent Health and Financial Performanc...N, March 12 Costing the global,pharmaceutical ind...g an,estimated 125,000 deaths per year in the Unit...ay, titled,"Ensuring Profitable Patient Adherence ...
...sing Avastin, researchers say , , WEDNESDA...roversial cancer drug Avastin can cause kidney dam...rong place, a study shows. , Avastin, whose generi...ng the action of vascular endothelial growth facto...
... Understanding of a,21st Century Epidemic, WASHIN...experts warn that Alzheimer,s disease will reach e...ve and unsustainable burdens in,terms of health ca...2/DC16505-a ), (Photo: http://www.newscom.com/c...
...try,s,preeminent race timing organization, announc...no 5K run/walk ( http://www.VigorLatino5K.com ) to...lifornia on Saturday, March,29, 2008. The Vigor La...n the area,s predominant Latino demographic and,it...
Other Medicine News:Health News:National Quality Forum Spring Conference; Leaders in Healthcare Quality to Focus on National Priorities and Care Coordination 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 2Health News:Ibuprofen destroys aspirin's positive effect on stroke risk 3Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 3Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3Health News:New Tools Boost Alzheimer's Awareness 2Health News:New Tools Boost Alzheimer's Awareness 3Health News:Race Central Launches Vigor Latino 5K Run/Walk, Promoting Hispanic Health, Fun and Fitness 2
(Date:11/25/2009)...ll/--ERT(Nasdaq: ERES ),announcedtodaythatDr.Micha...chneck,theCompany,sExecutiveVicePresidentandCFO,ar...thCareConferenceat1:30PMESTonDecember1,2009inNewYo...epresentationbyvisitingtheCompany,scorporatewebsit...dat http://www.corporate-ir.net/ireye/conflobby.zh...
(Date:11/25/2009)...heFDAgrantedtraditionalapprovalforINTELENCE®(...taseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspecif...whoareexperiencingvirologicfailurewithHIV-1strains...s.Thetraditionalapprovalisbasedon48-weekdatafromtw...rrentlymarketedintheU.S.byTibotecTherapeutics,adiv...
(Date:11/25/2009).../--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmerica...atitreceivedtheEnvironmentalResponsibilityandSusta...mit,sponsoredbytheCaliforniaManufacturersandTechno...sociation(IEA)andtheChemicalIndustryCouncilofCalif...awardavailablefromallthreeorganizationsandgainssub...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2DaVita CEO Kent Thiry Honored as One of Modern Healthcares 100 Most Powerful People in Healthcare 55783 1DaVita CEO Kent Thiry Honored as One of Modern Healthcares 100 Most Powerful People in Healthcare 55783 2Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21 2009 55779 1Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21 2009 55779 2Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 55775 1Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009 55775 2
...sts to evaluate immune function , , LENEXA, Kan.,...agnostics and biomedical-research laboratory speci...nch a new diagnostic assay designed to help physic...ho have recurrent infections. The company will int... the annual meeting of the American Academy of All...
...mpares Effectiveness of CT Colonography to Colonos...alue of CT colonography, also called virtual colon...ing coverage of these procedures as a diagnostic m...rous growths. Research findings from meta-analyses...ography appears most promising for screening asymp...
Other Medicine Technology:IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729 2Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed 2Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed 3
... one of our pipettors up and use it. Notice the ba...ht where they should beeven if youre left-handed. ...gned to help avoid repetitive stress injuries caus...e Palm Of Your Hand Start dispensing right away o...
...igh performance electronic pipetting!, Soft, feat...ce hand fatigue and strain , Stress-free tip eject...r easy volume identification , Accepts universal t...ip Low Retention and AdvanTip Precision Pipette Ti...
Finnpipette BioControl Multichannel, 8 Channel 50-300ul
... all liquid handling applications in the laborator...d operating buttons, and various dispensing techni...ing and diluting make this a lab favorite. It intu...ipette without any adverse effects on the variety ...
Medicine Products: